1. 274 Tumoral and peripheral immunophenotype of refractory vs relapse to PD-(L)1 blockade in patients with advanced non-small cell lung cancer. (10th December 2020) Authors: Ascierto, Maria; Hellmann, Matthew; Standifer, Nathan; Wu, Song; Si, Han; Morehouse, Chris; Rebelatto, Marlon; Abdullah, Shaad; Raja, Rajiv; Soria, Jean-Charles; Germa, Caroline; Barrett, Carl Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19–positive patients with cancer. (June 2020) Authors: Scotté, Florian; Minvielle, Etienne; Mir, Olivier; André, Fabrice; Barlesi, Fabrice; Soria, Jean-Charles Journal: European journal of cancer Issue: Volume 132(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours. (November 2018) Authors: Gazzah, Anas; Boni, Valentina; Soria, Jean-Charles; Calles, Antonio; Even, Caroline; Doger, Bernard; Mahjoubi, Linda; Bahleda, Rastislav; Ould-Kaci, Mahmoud; Esler, Anne; Nazabadioko, Serge; Calvo, Emiliano Journal: European journal of cancer Issue: Volume 104(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis. Issue 2 (February 2015) Authors: Verstovsek, Srdan; Hoffman, Ronald; Mascarenhas, John; Soria, Jean-Charles; Bahleda, Ratislav; McCoon, Patricia; Tang, Weifeng; Cortes, Jorge; Kantarjian, Hagop; Ribrag, Vincent Journal: Leukemia research Issue: Volume 39:Issue 2(2015:Feb.) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer. (November 2017) Authors: Soria, Jean-Charles; Adjei, Alex A.; Bahleda, Rastilav; Besse, Benjamin; Ferte, Charles; Planchard, David; Zhou, Jing; Ware, Joseph; Morrissey, Kari; Shankar, Geetha; Lin, Wei; Schutzman, Jennifer L.; Dy, Grace K.; Groen, Harry J.M. Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Issue 9 (September 2018) Authors: Sun, Roger; Limkin, Elaine Johanna; Vakalopoulou, Maria; Dercle, Laurent; Champiat, Stéphane; Han, Shan Rong; Verlingue, Loïc; Brandao, David; Lancia, Andrea; Ammari, Samy; Hollebecque, Antoine; Scoazec, Jean-Yves; Marabelle, Aurélien; Massard, Christophe; Soria, Jean-Charles; Robert, Charlotte; ... Journal: Lancet oncology Issue: Volume 19:Issue 9(2018) Page Start: 1180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody. (October 2016) Authors: Michot, Jean-Marie; Mazeron, Renaud; Dercle, Laurent; Ammari, Samy; Canova, Charles; Marabelle, Aurelien; Rose, Shelonitda; Rubin, Eric; Deutsch, Eric; Soria, Jean-Charles; Ribrag, Vincent; Levy, Antonin Journal: European journal of cancer Issue: Volume 66(2016) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors. Issue 4 (July 2018) Authors: Koeppel, Florence; Bobard, Alexandre; Lefebvre, Céline; Pedrero, Marion; Deloger, Marc; Boursin, Yannick; Richon, Catherine; Chen-Min-Tao, Romy; Robert, Guillaume; Meurice, Guillaume; Rouleau, Etienne; Michiels, Stefan; Massard, Christophe; Scoazec, Jean-Yves; Solary, Eric; Soria, Jean-Charles; A... Journal: Cancer journal Issue: Volume 24:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial. Issue 8 (August 2015) Authors: Soria, Jean-Charles; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Li, Wei; Isla, Dolores; Guclu, Salih Z; Morabito, Alessandro; Min, Young J; Ardizzoni, Andrea; Gadgeel, Shirish M; Wang, Bushi; Chand, Vikram K; Goss, Glenwood D Journal: Lancet oncology Issue: Volume 16:Issue 8(2015:Aug.) Page Start: 897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial. Issue 8 (August 2015) Authors: Soria, Jean-Charles; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Li, Wei; Isla, Dolores; Guclu, Salih Z; Morabito, Alessandro; Min, Young J; Ardizzoni, Andrea; Gadgeel, Shirish M; Wang, Bushi; Chand, Vikram K; Goss, Glenwoo... Journal: Lancet oncology Issue: Volume 16:Issue 8(2015:Aug.) Page Start: 897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗